Full Library
Multidrug-Resistant Organisms: Posttransplant Management for Extended-Spectrum Beta-Lactamase Producers and Carbapenem-Resistant Enterobacterales
Resource type
Book Section
Authors/contributors
- Morris, Michele I. (Editor)
- Kotton, Camille Nelson (Editor)
- Wolfe, Cameron (Editor)
- Howard-Anderson, Jessica (Author)
- Pouch, Stephanie M. (Author)
Title
Multidrug-Resistant Organisms: Posttransplant Management for Extended-Spectrum Beta-Lactamase Producers and Carbapenem-Resistant Enterobacterales
Abstract
The incidence of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales (ESBL-EB) and carbapenem-resistant Enterobacterales (CRE) infections has been increasing worldwide, although the prevalence and mechanism of resistance vary by geographic region and institutional patterns of resistance. These multidrug-resistant infections are challenging to diagnose and treat and can cause significant morbidity and mortality in transplant patients. In this chapter we highlight recent trends in epidemiology, including risk factors for acquiring ESBL-EB and CRE, clinical outcomes, and new strategies for diagnosis and treatment in both solid organ and hematopoietic stem cell transplant patients with ESBL-EB and CRE infections.
Book Title
Emerging Transplant Infections
Date
2021
Publisher
Springer International Publishing
Place
Cham
Pages
313-342
ISBN
978-3-030-01751-4
Accessed
10/23/21, 9:33 AM
Short Title
Multidrug-Resistant Organisms
Language
en
Library Catalog
DOI.org (Crossref)
Extra
Citation
Howard-Anderson, J., & Pouch, S. M. (2021). Multidrug-Resistant Organisms: Posttransplant Management for Extended-Spectrum Beta-Lactamase Producers and Carbapenem-Resistant Enterobacterales. In M. I. Morris, C. N. Kotton, & C. Wolfe (Eds.), Emerging Transplant Infections (pp. 313–342). Springer International Publishing. https://doi.org/10.1007/978-3-030-01751-4_14-2
TEXTBOOKS
Link to this record